The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according to a new report by the Federal Trade Commission released on Tuesday.

Al Roberts and Travis Hale, the owners of Remington Drug Company in Remington, Va., hosted Andrew Ferguson, chair of the ...

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being ...

Pharmacy benefit managers negotiate pricing and conditions for access to drugs, process prescription claims and manage retail ...

The Federal Trade Commission’s legal action against the three largest pharmacy benefit managers will move forward after a federal judge rejected their bid to halt the case. In a court filing ...

The U.S. House is renewing a push to take on pharmacy benefit managers that play an important role in the cost of prescription drugs.

This system has come under scrutiny from the Federal Trade Commission, which in a July 2024 report called pharmacy benefit managers “the powerful middlemen inflating drug costs and squeezing ...

News Briefs - Healthcare Industry Prepares for Stricter FTC Merger Guidelines - The Federal Trade Commission will continue to use stricter ...

The U.S. House is renewing a push to take on pharmacy benefit managers that play an important ... PBMs have been targeted by Congress and the Federal Trade Commission for their powerful role ...